# ProShares UltraShort Nasdaq Biotechnology (BIS)

Source: https://www.quantisnow.com/company/BIS
Generated: 2026-11-11T22:05:33.038Z

- Type: ETF (exchange-traded fund), not a company
- Ticker: BIS
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## About

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®.
 The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

## Latest BIS news and filings

- 2026-05-11 22:30 UTC [Earnings Date] [ProShares Announces ETF Share Splits](https://www.quantisnow.com/insight/proshares-announces-etf-share-splits-6546082)
- 2021-12-17 16:15 UTC [Market Insight] [Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index](https://www.quantisnow.com/insight/psychedelics-company-compass-pathways-to-join-nasdaq-biotechnology-index-2157450)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BIS
- Earnings history: https://www.quantisnow.com/earnings/BIS
- Dividend history: https://www.quantisnow.com/dividends/BIS
- Insider transactions: https://www.quantisnow.com/insiders/BIS
- Options chain: https://www.quantisnow.com/options/BIS
- SEC 8-K filings only: https://www.quantisnow.com/company/BIS/8-k
- RSS and alerts for BIS: https://www.quantisnow.com/docs/rss-feeds.md